Determinants of COVID-19-related lethality in multiple sclerosis: a meta-regression of observational studies
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Determinants of COVID-19-related lethality in multiple sclerosis: a meta-regression of observational studies
Authors
Keywords
-
Journal
JOURNAL OF NEUROLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-01-05
DOI
10.1007/s00415-021-10951-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Disease modifying therapies and Covid‐19 severity in Multiple Sclerosis
- (2021) Maria Pia Sormani et al. ANNALS OF NEUROLOGY
- Incidence and clinical outcome of Coronavirus disease 2019 in a cohort of 11,560 Brazilian patients with multiple sclerosis
- (2021) et al. Multiple Sclerosis Journal
- COVID-19 in multiple sclerosis and neuromyelitis optica spectrum disorder patients in Latin America
- (2021) Ricardo Alonso et al. Multiple Sclerosis and Related Disorders
- COVID-19 in Patients with Multiple Sclerosis: Associations with Disease-Modifying Therapies
- (2021) Anthony T. Reder et al. CNS DRUGS
- Disease-modifying therapies and SARS-CoV-2 vaccination in multiple sclerosis: an expert consensus
- (2021) Diego Centonze et al. JOURNAL OF NEUROLOGY
- Clinical course and outcome of SARS-CoV-2 infection in multiple sclerosis patients treated with disease-modifying therapies — the Polish experience
- (2021) Agata Czarnowska et al. Neurologia i Neurochirurgia Polska
- Outcomes and Risk Factors Associated With SARS-CoV-2 Infection in a North American Registry of Patients With Multiple Sclerosis
- (2021) Amber Salter et al. JAMA Neurology
- Registry of patients with multiple sclerosis and COVID-19 infection in Saudi Arabia
- (2021) Foziah Alshamrani et al. Multiple Sclerosis and Related Disorders
- Risk and outcomes of COVID‐19 in patients with multiple sclerosis
- (2021) Irene Moreno‐Torres et al. EUROPEAN JOURNAL OF NEUROLOGY
- Increased risk of death from COVID-19 in multiple sclerosis: a pooled analysis of observational studies
- (2021) Luca Prosperini et al. JOURNAL OF NEUROLOGY
- COVID-19 severity and mortality in multiple sclerosis are not associated with immunotherapy: Insights from a nation-wide Austrian registry
- (2021) Gabriel Bsteh et al. PLoS One
- The outcome of a national MS-Covid-19 study: What the Turkish MS cohort reveals?
- (2021) S. Sen et al. Multiple Sclerosis and Related Disorders
- Multiple sclerosis, neuromyelitis optica spectrum disorder and COVID-19: A pandemic year in Czechia
- (2021) Dominika Stastna et al. Multiple Sclerosis and Related Disorders
- DMTs and Covid‐19 severity in MS: a pooled analysis from Italy and France
- (2021) Maria Pia Sormani et al. Annals of Clinical and Translational Neurology
- COVID-19 Among Patients With Multiple Sclerosis
- (2021) Mahdi Barzegar et al. Neurology-Neuroimmunology & Neuroinflammation
- SARS-CoV-2 Infection in Multiple Sclerosis
- (2021) Georgina Arrambide et al. Neurology-Neuroimmunology & Neuroinflammation
- Humoral- and T-Cell–Specific Immune Responses to SARS-CoV-2 mRNA Vaccination in Patients With MS Using Different Disease-Modifying Therapies
- (2021) Carla Tortorella et al. NEUROLOGY
- Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis
- (2021) Steve Simpson-Yap et al. NEUROLOGY
- COVID-19 Severity in Multiple Sclerosis
- (2021) Maria Pia Sormani et al. Neurology-Neuroimmunology & Neuroinflammation
- Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy
- (2020) Graziano Onder et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- COVID-19 and management of neuroimmunological disorders
- (2020) Hans-Peter Hartung et al. Nature Reviews Neurology
- COVID-19 in multiple sclerosis: The Dutch experience
- (2020) Floor C Loonstra et al. Multiple Sclerosis Journal
- Clinical Characteristics and Outcomes in Patients With Coronavirus Disease 2019 and Multiple Sclerosis
- (2020) Céline Louapre et al. JAMA Neurology
- The underpinning biology relating to multiple sclerosis disease modifying treatments during the COVID-19 pandemic
- (2020) David Baker et al. Multiple Sclerosis and Related Disorders
- Three Decades of Interferon-β in Multiple Sclerosis: Can We Repurpose This Information for the Management of SARS-CoV2 Infection?
- (2020) Martina Severa et al. Frontiers in Immunology
- COVID-19 outcomes in MS
- (2020) Erica Parrotta et al. Neurology-Neuroimmunology & Neuroinflammation
- The risk of infection in patients with multiple sclerosis treated with disease-modifying therapies: A Delphi consensus statement
- (2020) Lucia Moiola et al. Multiple Sclerosis Journal
- Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
- (2020) Qian Zhang et al. SCIENCE
- Characteristics of COVID-19 disease in multiple sclerosis patients
- (2020) Mahdi Barzegar et al. Multiple Sclerosis and Related Disorders
- COVID-19 in MS and NMOSD: A multicentric online national survey in Chile
- (2020) Ethel Ciampi et al. Multiple Sclerosis and Related Disorders
- Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies
- (2019) Gustavo Luna et al. JAMA Neurology
- Consequences of B-cell-depleting therapy: hypogammaglobulinemia and impaired B-cell reconstitution
- (2018) Keith A Sacco et al. Immunotherapy
- Disease-modifying drugs for multiple sclerosis and infection risk: a cohort study
- (2018) José Maria Andreas Wijnands et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Multiple sclerosis
- (2018) Alan J Thompson et al. LANCET
- Hospital admission due to infections in multiple sclerosis patients
- (2013) S. Montgomery et al. EUROPEAN JOURNAL OF NEUROLOGY
- Mortality in patients with multiple sclerosis
- (2013) A. Scalfari et al. NEUROLOGY
- Inhibition of Pyrimidine Biosynthesis Pathway Suppresses Viral Growth through Innate Immunity
- (2013) Marianne Lucas-Hourani et al. PLoS Pathogens
- Cause of death in MS: long-term follow-up of a randomised cohort, 21 years after the start of the pivotal IFNβ-1b study
- (2012) Douglas S Goodin et al. BMJ Open
- Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
- (2010) Andreas Stang EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Mortality in multiple sclerosis: a review
- (2010) P. Ragonese et al. EUROPEAN JOURNAL OF NEUROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation